Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
09/28/2011 | CN102203055A Nitric oxide releasing amino acid ester compound, composition and method of use |
09/28/2011 | CN102201432A Organic light-emitting device and method of manufacturing the same |
09/28/2011 | CN102199148A Benzsulfamide derivatives and medicinal composition thereof |
09/28/2011 | CN102199119A Oxime ester photoinitiators |
09/28/2011 | CN102199118A Oxo-bi(N-Methylphthalimide) synthesis method |
09/28/2011 | CN102199117A Method for preparing amorphous zafirlukast solid |
09/28/2011 | CN101696185B Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid |
09/28/2011 | CN101633637B 8-oxo-8H-acenaphtho[1,2-b]pyrrole derivative |
09/28/2011 | CN101538289B Monomer for organic electro-phosphorescent polymer |
09/27/2011 | US8026375 Transition metal catalyzed synthesis of N-aminoindoles |
09/27/2011 | US8026371 Hydroxamates as therapeutic agents |
09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
09/27/2011 | US8026270 Benzo [F] isoindoles as EP4 receptor agonists |
09/27/2011 | US8026269 Isoindoline compounds and methods of making and using the same |
09/27/2011 | CA2511307C Viral polymerase inhibitors |
09/27/2011 | CA2386514C Antifungal enediynes |
09/27/2011 | CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
09/22/2011 | WO2011116356A2 Positive allosteric modulators of group ii mglurs |
09/22/2011 | WO2011115527A1 New biologically active compound n-[3-(4-nitrophenylamino)-indol-2-ylmethylene]aminoguanidine hydrochloride with anti-inflammatory activity |
09/22/2011 | WO2011115378A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
09/22/2011 | WO2011115069A1 Exhaustive searching for crystals |
09/22/2011 | WO2011114886A1 Method for producing organic electroluminescence element |
09/22/2011 | WO2011060297A3 Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions |
09/22/2011 | US20110230651 Benzenesulfonamide derivatives and pharmaceutical composition therof |
09/22/2011 | US20110230617 Radiation-curable coating materials |
09/22/2011 | US20110230524 Substituted 2-(5-hydroxy-2-methyl-1h-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases |
09/22/2011 | US20110230488 Hybrid-ionone and curcumin molecules as anticancer agents |
09/22/2011 | US20110230454 (aza)indole derivative and use thereof for medical purposes |
09/22/2011 | US20110230452 Compounds and methods for the treatment of pain and other diseases |
09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
09/22/2011 | US20110230442 Na channels, disease, and related assays and compositions |
09/22/2011 | US20110230350 Aryl-and hetarylsulfonamides as active ingredients against abiotic plant stress |
09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
09/22/2011 | US20110227053 Novel chrysene derivatives and organic electrical device using the same |
09/22/2011 | US20110227002 Aromatic imide-based dispersant for carbon nanotubes and carbon nanotube composition comprising the same |
09/21/2011 | EP2366701A1 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof |
09/21/2011 | EP2366690A1 Salts and crystalline salt forms of an 2-indolinone derivative |
09/21/2011 | EP2366689A1 Saccharin salts and crystalline salt forms of an 2-indolinone derivative |
09/21/2011 | EP2366688A1 Salts and crystalline salt forms of an 2-indolinone derivative |
09/21/2011 | EP2366687A2 Benzenesulfonamide derivatives and pharmaceutical composition thereof |
09/21/2011 | EP1771413B1 Benzofuran derivatives as selective androgen receptor modulators (sarms) |
09/21/2011 | CN102197027A Material for organic electronic device, and organic electronic device using the same |
09/21/2011 | CN102197026A Method for the synthesis of a ramipril intermediate |
09/21/2011 | CN102191042A Triarylamine hole transport material and preparation method thereof |
09/21/2011 | CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs |
09/21/2011 | CN102190614A Application of natural seaweed endophytic fungus diterpene alkaloid compound |
09/21/2011 | CN102190613A Method for preparing carvedilol |
09/21/2011 | CN102190612A Endophytic fungus diterpene alkaloid compound of natural seaweed as well as preparation method and application thereof |
09/21/2011 | CN102190589A Amino acid ionic liquid for foodstuffs and medical treatments |
09/21/2011 | CN101624364B CTP synthesis technology of rubber scorch retarder and device thereof |
09/20/2011 | US8022295 Photoelectric conversion devices |
09/20/2011 | US8022230 Dimeric IAP inhibitors |
09/20/2011 | US8022229 Process for the preparation of alkyl 5-(dicarboximido) levulinate and alkyl 4-oxo-pentenoate |
09/20/2011 | US8022094 Carvedilol phosphate |
09/20/2011 | US8021764 Phenylcarbazole-based compound and organic electroluminescent device employing the same |
09/20/2011 | CA2669311C Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
09/20/2011 | CA2657106C Aminoindane derivative or salt thereof |
09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
09/20/2011 | CA2115828C Calcium receptor active molecules |
09/15/2011 | WO2011111930A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
09/15/2011 | WO2011111675A1 Novel indole derivative |
09/15/2011 | WO2011111423A1 Method for producing iodinated aromatic compound |
09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
09/15/2011 | WO2011054837A3 Bifunctional prodrugs and drugs |
09/15/2011 | WO2011018144A3 Phenanthro[1,10,9,8-c,d,e,f,g]carbazole polymers and their use as organic semiconductors |
09/15/2011 | US20110224443 Preparation of fosamprenavir calcium |
09/15/2011 | US20110224274 New Therapeutic Agents |
09/15/2011 | US20110224213 Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic Agents |
09/15/2011 | US20110224184 Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis |
09/14/2011 | EP2365735A2 Luminescent element material and luminescent element comprising the same |
09/14/2011 | EP2364970A1 Processes and intermediates |
09/14/2011 | EP2364969A1 Salts and crystalline salt forms of an 2-indolinone derivative |
09/14/2011 | EP2364968A1 Salts and crystalline salt forms of an 2-indolinone derivative |
09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
09/14/2011 | EP1346982B1 Vla-4 inhibitors |
09/14/2011 | CN1942440B Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives |
09/14/2011 | CN102186860A N-phenyl carbazole-based host material for light-emitting diodes |
09/14/2011 | CN102186859A Host material for light-emitting diodes |
09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
09/14/2011 | CN102186833A MIF modulators |
09/14/2011 | CN102186820A Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
09/14/2011 | CN102186819A Aromatic amine derivative and organic electroluminescent device using the same |
09/14/2011 | CN102186818A 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
09/14/2011 | CN102186803A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
09/14/2011 | CN102180828A Chiral indolinone spiropentacyclic skeleton compounds and asymmetric synthesis thereof |
09/14/2011 | CN102180827A Purification method of Yuehchukene |
09/14/2011 | CN102180826A Histone deacetylase inhibitor containing alpha amino acid structure and application thereof |
09/14/2011 | CN102180825A Method for preparing 3-indole arylmethanesulfonamide |
09/14/2011 | CN101709049B Method for extracting L-tryptophan |
09/14/2011 | CN101633635B Crystalline form of (2r,4r)-monatin potassium salt and sweetener composition containing same |
09/14/2011 | CN101163696B Histone deacetylase inhibitors |
09/14/2011 | CN101048377B Oxime ester compound and photopolymerization initiator comprising the compound |
09/13/2011 | USRE42700 Induction of apoptosis in cancer cells |
09/13/2011 | US8017644 2-arylindole derivatives as nPGES-1 inhibitors |
09/13/2011 | US8017640 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
09/13/2011 | US8017630 Cyclohexylacetic acid compounds |
09/13/2011 | US8017104 Large stoke shift dye used for optical imaging |